Robert Calandra | Jan 26, 2003 | 5 min read
Ensconced in a darkened room at GlaxoSmithKline's suburban Philadelphia campus, Lara Kallander brings up an image of an X-ray crystallized compound on a wall screen. The image looks like a heap of brightly colored children's pickup-sticks arrayed at random angles. Kallander puts on a weighty pair of 3-D glasses. At first the left eye is annoyingly fuzzy, as if the lens is smudged. Then she hits a few keystrokes on the computer and suddenly the pickup sticks seem to pop off the screen. The lin